Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.23B |
| 2 |
Salesforce
CRM
|
+$777M |
| 3 |
Flutter Entertainment
FLUT
|
+$622M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$569M |
| 5 |
Amazon
AMZN
|
+$566M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$1.95B |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
+$738M |
| 3 |
Alibaba
BABA
|
+$328M |
| 4 |
Vistra
VST
|
+$313M |
| 5 |
Wells Fargo
WFC
|
+$265M |
Sector Composition
| 1 | Technology | 25.45% |
| 2 | Financials | 12.86% |
| 3 | Industrials | 11.53% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Healthcare | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Arteris
AIP
$370M
| $140K | ﹤0.01% |
13,704
+237
| +2% | +$2.42K |
|
3477
Voyager Therapeutics
VYGR
$221M
| $137K | ﹤0.01% |
24,172
+1,645
| +7% | +$9.33K |
|
|
ME
3478
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $135K | ﹤0.01% |
41,547
-911
| -2% | -$2.96K |
|
3479
Cerus
CERS
$247M
| $134K | ﹤0.01% |
86,787
+6,665
| +8% | +$10.3K |
|
3480
Stoke Therapeutics
STOK
$1.17B
| $133K | ﹤0.01% |
+12,065
| New | +$133K |
|
3481
KalVista Pharmaceuticals
KALV
$784M
| $132K | ﹤0.01% |
15,640
+1,083
| +7% | +$9.17K |
|
|
ENFN
3482
DELISTED
Enfusion, Inc.
ENFN
| $132K | ﹤0.01% |
12,825
+722
| +6% | +$7.44K |
|
3483
Mizuho Financial
MFG
$82.4B
| $132K | ﹤0.01% |
26,957
+1,079
| +4% | +$5.28K |
|
3484
Cricut
CRCT
$1.3B
| $130K | ﹤0.01% |
22,888
+1,166
| +5% | +$6.65K |
|
3485
Mama's Creations
MAMA
$352M
| $130K | ﹤0.01% |
16,346
+283
| +2% | +$2.25K |
|
3486
Terns Pharmaceuticals
TERN
$639M
| $130K | ﹤0.01% |
23,400
+2,753
| +13% | +$15.3K |
|
3487
Copel
ELP
$6.75B
| $129K | ﹤0.01% |
21,699
+382
| +2% | +$2.27K |
|
3488
Editas Medicine
EDIT
$245M
| $127K | ﹤0.01% |
100,164
+8,448
| +9% | +$10.7K |
|
3489
Allbirds
BIRD
$48.9M
| $125K | ﹤0.01% |
17,882
-120
| -0.7% | -$836 |
|
3490
MeiraGTx Holdings
MGTX
$590M
| $123K | ﹤0.01% |
20,270
+7,569
| +60% | +$46.1K |
|
3491
Viemed Healthcare
VMD
$263M
| $123K | ﹤0.01% |
15,380
+295
| +2% | +$2.37K |
|
|
DOYU
3492
DouYu International Holdings
DOYU
$249M
| $123K | ﹤0.01% |
10,981
-3,670
| -25% | -$41.1K |
|
|
GDO
3493
Western Asset Global Corporate Defined Opportunity Fund
GDO
$89.8M
| $123K | ﹤0.01% |
10,829
-43
| -0.4% | -$487 |
|
3494
Erasca
ERAS
$440M
| $122K | ﹤0.01% |
48,671
+11,290
| +30% | +$28.3K |
|
3495
SES AI
SES
$402M
| $119K | ﹤0.01% |
54,512
+4,798
| +10% | +$10.5K |
|
3496
Backblaze
BLZE
$528M
| $119K | ﹤0.01% |
19,824
+343
| +2% | +$2.07K |
|
3497
MacroGenics
MGNX
$108M
| $117K | ﹤0.01% |
35,979
+1,231
| +4% | +$4K |
|
3498
Y-mAbs Therapeutics
YMAB
$390M
| $117K | ﹤0.01% |
14,923
+367
| +3% | +$2.87K |
|
3499
EyePoint Pharmaceuticals
EYPT
$957M
| $117K | ﹤0.01% |
15,657
+2,177
| +16% | +$16.2K |
|
|
DADA
3500
DELISTED
Dada Nexus
DADA
| $115K | ﹤0.01% |
95,138
+273
| +0.3% | +$330 |
|